@FiercePharma: Top-read on FP this weekend: Roche and Cipla are ordered to mediate in a new twist on Indian IP fights.Story | Follow @FiercePharma
@TracyStaton: Trending now @FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. Story | Follow @TracyStaton
@EricPFierce: In Allergan and Valeant takeover fight, silence is Goldman. More | Follow @EricPFierce
@CarlyHFierce: ICYMI--NYT: Goldman Sachs caught in the middle of Valeant, Allergan takeover fight. Article | Follow @CarlyHFierce
@JustinHFierce: PetVivo ($PETV) updates study on Kush medical device to treat animal osteoarthritis with Gel-Del, CEO Lai: "Mobility." Release | Follow @JustinHFierce
> Could Pfizer nab AstraZeneca with pipeline-based payouts? Maybe, but cash is easier. Story
> Sources: Bayer, J&J's Xarelto faces first U.S. lawsuits. More
> GlaxoSmithKline ($GSK) will close a plant in Romania, taking 236 jobs with it by 2015. Report
>Novo Nordisk ($NVO) says it sees 'no strategic reason' for big mergers. Story (sub. req.)
> Sanofi ($SNY) and Medtronic ($MDT) have announced a strategic alliance in diabetes. Release
> A Novartis ($NVS) facility in Holly Springs, NC, has become the U.S.' first pandemic-ready site licensed by the FDA to produce cell-culture flu vaccines. Release
> New study data shows that Lundbeck's Brintellix improved cognitive function in adult patients with major depression. Report
> Former Glaxo unit Convergence Pharmaceuticals is considering an IPO to raise at least £50 million ($85 million). More
Medical Device News
@FierceMedDev: Chrono Therapeutics snares $32M in Series A money for wearable smoking cessation device. More | Follow @FierceMedDev
@StacyALawrence: Mobile medical app brings laboratory testing to the home. Story | Follow @StacyALawrence
@MichaelGFierce: UCSB study: New silver nanoparticles dissolve if they don't hit their mark. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: C.R. Bard wins unanimous FDA panel vote for drug-eluting balloon catheter. Article | Follow @EmilyWFierce
> Obesity device before FDA panel despite not meeting primary endpoints. More
> $90M later, Apollo rebrands Lap-Band and hopes to best Allergan's efforts. Article
> iWatch to unite Apple healthcare strategy? Item
Biotech News
@FierceBiotech: What's next in diabetes drugs? The pulse of R&D at ADA14. More | Follow @FierceBiotech
@JohnCFierce: Vertex down about 8% now as this Porges note rattles investors. Story | Follow @JohnCFierce
@DamianFierce: Check out FierceBiotech's full 2014 ADA coverage here. | Follow @DamianFierce
> Once-monthly MS drug from Biogen Idec, AbbVie clears Phase III hurdle. More
> Boehringer, Lilly creep up on Sanofi with Lantus biosimilar. Story
> Sanofi's Lantus heir beats its forebear in controlling diabetes. Article
CRO News
> InVentiv, Oncobiologics kick off their biosimilar alliance, target Humira. More
> Karyopharm taps CRO Veristat for cancer R&D. Story
> Quintiles signs an expansive deal to chart effects of physical therapy. Article
> Korean pharma booster recruits Novotech to boost local R&D. Report
> After a year of dealmaking, PRA settles in with a new identity. News
Biotech IT News
> EMA backtracks on clinical trial data download ban. News
> Illumina working to turn smartphones into 'molecular stethoscopes.' More
> Google inks deal with Autism Speaks, commits to housing 10,000 whole genomes. Article
> Pfizer strikes tech-enabled drug discovery deal with X-Chem. Story
> AstraZeneca sponsors diabetes patient registry. More
And Finally... Aspirin may no longer be considered the best drug for preventing strokes in people with atrial fibrillation. More